4 Generations of Knowledge
3 Decades of Investing in Innovation
3 Decades of Investing in Innovation
We Help Entrepreneurs Build Market Leaders
Focused on Early Stage IT and Healthcare Investments
A Network of 400 Companies and 4,000 Executives
USVP IN NUMBERS
$3.9B
Total Invested
498
Companies
89
IPOs
NEWS
July 28, 2020
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Business WirePress
July 21, 2020
Epsagon Increases Total Fundraising to $30M to Become the Leading Applied Observability Platform Across Microservices Environments
Epsagon Increases Total Fundraising to $30M to Become the Leading Applied Observability Platform Across Microservices Environments
DTCPPress
